Literature DB >> 21306400

The magnitude of CD4(+) T-cell activation rather than TCR diversity determines the outcome of Leishmania infection in mice.

L Xin1, J L Wanderley, Y Wang, D A Vargas-Inchaustegui, L Soong.   

Abstract

CD4(+) T cells play a critical role in determining the disease outcome in murine cutaneous leishmaniasis, and selective usage of T-cell receptor (TCR) is implied in promoting Leishmania major infection. However, little information is available on TCR usage in Leishmania-specific, IFN-γ-producing CD4(+) T cells. In this study, we investigated the TCR diversity and activation of CD4(+) T cells in a nonhealing model associated with L. amazonensis (La) infection and a self-healing model associated with L. braziliensis (Lb) infection. While marked expansion in the absolute number of several subsets was observed in Lb-infected mice, the percentages of TCR Vβ(+) CD4(+) -cell subsets were comparable in draining LN- and lesion-derived T cells in two infection models. We found that multiple TCRCD4(+) T cells contributed collectively and comparably to IFN-γ production and that the overall levels of IFN-γ production positively correlated with the control of Lb infection. Moreover, pre-infection with Lb parasites provided cross-protection against secondary La infection, owing to an enhanced magnitude of T-cell activation and IFN-γ production. Collectively, this study suggests that the magnitude of CD4(+) T-cell activation, rather than the TCR diversity, is the major determining factor for the outcome of Leishmania infection.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21306400      PMCID: PMC4118816          DOI: 10.1111/j.1365-3024.2010.01268.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  35 in total

1.  Rapid expansion and IL-4 expression by Leishmania-specific naive helper T cells in vivo.

Authors:  Daniel B Stetson; Markus Mohrs; Valerie Mallet-Designe; Luc Teyton; Richard M Locksley
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

Review 2.  The immunology of susceptibility and resistance to Leishmania major in mice.

Authors:  David Sacks; Nancy Noben-Trauth
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

3.  Intestinal and splenic T cell responses to enteric Listeria monocytogenes infection: distinct repertoires of responding CD8 T lymphocytes.

Authors:  J W Huleatt; I Pilip; K Kerksiek; E G Pamer
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

4.  IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection.

Authors:  D E Jones; L U Buxbaum; P Scott
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

5.  Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection.

Authors:  Douglas E Jones; Mark R Ackermann; Ulrike Wille; Christopher A Hunter; Phillip Scott
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

6.  Rapid IL-4 production by Leishmania homolog of mammalian RACK1-reactive CD4(+) T cells in resistant mice treated once with anti-IL-12 or -IFN-gamma antibodies at the onset of infection with Leishmania major instructs Th2 cell development, resulting in nonhealing lesions.

Authors:  Pascal Launois; Alain Gumy; Hayo Himmelrich; Richard M Locksley; Martin Röcken; Jacques A Louis
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

7.  Plasmodium falciparum apical membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and memory T cells.

Authors:  Maria Cecilia Huaman; Gregory E D Mullen; Carole A Long; Siddhartha Mahanty
Journal:  Vaccine       Date:  2009-07-08       Impact factor: 3.641

8.  Analysis of T helper cell responses during infection with Leishmania amazonensis.

Authors:  Jiaxiang Ji; Jiaren Sun; Hai Qi; Lynn Soong
Journal:  Am J Trop Med Hyg       Date:  2002-04       Impact factor: 2.345

9.  Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis.

Authors:  Jiaxiang Ji; Jiaren Sun; Lynn Soong
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children.

Authors:  Zhong Chen Kou; Joshua S Puhr; Samuel S Wu; Maureen M Goodenow; John W Sleasman
Journal:  J Infect Dis       Date:  2003-01-24       Impact factor: 5.226

View more
  8 in total

Review 1.  Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.

Authors:  Lynn Soong; Calvin A Henard; Peter C Melby
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

2.  Intralesional uridine-5'-triphosphate (UTP) treatment induced resistance to Leishmania amazonensis infection by boosting Th1 immune responses and reactive oxygen species production.

Authors:  Camila Marques-da-Silva; Mariana M Chaves; Maria Luiza Thorstenberg; Vanessa R Figliuolo; Flávia S Vieira; Suzana P Chaves; José Roberto Meyer-Fernandes; Bartira Rossi-Bergmann; Luiz Eduardo Baggio Savio; Robson Coutinho-Silva
Journal:  Purinergic Signal       Date:  2018-04-21       Impact factor: 3.765

3.  Phosphatidylserine exposure on the surface of Leishmania amazonensis amastigotes modulates in vivo infection and dendritic cell function.

Authors:  J L M Wanderley; P E Thorpe; M A Barcinski; L Soong
Journal:  Parasite Immunol       Date:  2013 Mar-Apr       Impact factor: 2.280

4.  High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection.

Authors:  Lucas Sánchez-Sampedro; Carmen Elena Gómez; Ernesto Mejías-Pérez; Carlos Oscar S Sorzano; Mariano Esteban
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

5.  Subversion of Immunity by Leishmania amazonensis Parasites: Possible Role of Phosphatidylserine as a Main Regulator.

Authors:  Joao Luiz Mendes Wanderley; Jaqueline França Costa; Valéria Matos Borges; Marcello Barcinski
Journal:  J Parasitol Res       Date:  2012-02-02

6.  Interferon gamma in leishmaniasis.

Authors:  Peter E Kima; Lynn Soong
Journal:  Front Immunol       Date:  2013-06-19       Impact factor: 7.561

Review 7.  Role of Cytokines in Experimental and Human Visceral Leishmaniasis.

Authors:  Mukesh Samant; Utkarsha Sahu; Satish Chandra Pandey; Prashant Khare
Journal:  Front Cell Infect Microbiol       Date:  2021-02-18       Impact factor: 5.293

8.  Subversion and Utilization of Host Innate Defense by Leishmania amazonensis.

Authors:  Lynn Soong
Journal:  Front Immunol       Date:  2012-03-21       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.